Vir Biotechnology, Inc. (VIR) › Operating IncomeVir Biotechnology, Inc. (VIR) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2017: -$81.50M2018: -$118.69M2019: -$177.98M2020: -$296.98M2021: $420.75M2022: $833.07M2023: -$684.30M2024: -$587.16M2025: -$479.33M-$479.33M2017Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$479.33M+18.4%2024-$587.16M+14.2%2023-$684.30M-182.1%2022$833.07M+98.0%2021$420.75M+241.7%2020-$296.98M-66.9%2019-$177.98M-50.0%2018-$118.69M-45.6%2017-$81.50M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share